🔊CEOInterviews

Anthony Hunt on business case

From Go with the Flow Expert Panel Discussion | Hosted by Tony Hunt CEO - Repligen Corporation (06/29/21) · · Repligen

“The business case question always comes back, and I think it's a mix. On the one hand, you do have tangible benefit—you can calculate the return on investment for Flow VP. If you don't pull the sample anymore and get lead time reduction or no person in the QC lab coming in at night, that's a positive. But we also try to convince people of the less tangible benefits, like additional data to better understand the process, leading to a better manufacturing process at product launch.”

Anthony Hunt
Executive Chair, REPLIGEN CORP
Policy Impact business caseprocess understandingmanufacturingtechnology investment

On , Anthony Hunt, Executive Chair at REPLIGEN CORP, spoke about business case during Go with the Flow Expert Panel Discussion | Hosted by Tony Hunt CEO - Repligen Corporation (06/29/21) on Repligen.

Go with the Flow Expert Panel Discussion | Hosted by Tony Hunt CEO - Repligen Corporation (06/29/21)
Watch on YouTube
Go with the Flow Expert Panel Discussion | Hosted by Tony Hunt CEO - Repligen Corporation (06/29/21)
Repligen
Watch on YouTube
... to evaluate the flow BP technology maybe start with Ral yeah thanks Tony for for that question I think um when we were looking ...
Anthony Hunt

About Anthony Hunt

Executive Chair · REPLIGEN CORP

Anthony Hunt, Executive Chair at Repligen, hosted a "Go with the Flow" expert panel discussion on June 29, 2021. During the event, Hunt described Repligen as "very much committed" to process analytical technology (PAT) and said the company views inline monitoring as "the new wave." He stated that the business case for PAT tools involves both tangible benefits, such as lead time reduction, and less tangible benefits like additional process understanding. Hunt identified risk aversion as the biggest barrier to adoption of PAT technologies, noting that companies see introducing new technology as adding risk and potentially delaying timelines. Hunt also discussed challenges in implementing PAT, including the need for fully validated analytical methods and convincing health authorities that the tools are equivalent or better than current control strategies. He said that continuous manufacturing for downstream processes would not be possible without inline real-time monitoring, and that digital twins require real-time data from online PAT tools. Hunt noted that collecting more data can expose process inconsistencies, but said regulatory authorities want transparency and that high-quality data can help demonstrate process control.

Profile compiled from Anthony Hunt's verified public interviews and appearances. See all quotes & transcripts →

More from Anthony Hunt REPLIGEN CORP (RGEN) Full Transcript Explore All Executives